The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.
Quantitation of Ecdysterone and Targeted Analysis of WADA-Prohibited Anabolic Androgen Steroids, Hormones, and Metabolic Modulators in Ecdysterone-Containing Dietary Supplements
Open accessAbstract
The aim of our research was to perform a comprehensive study of ecdysterone (ECD)-containing dietary supplements (DSs). Two analytical methods were optimised according to the expected concentration of the target compounds: quantitation of ECD by liquid chromatography (LC) coupled to diode array detector (DAD), and limit test for 47 World Anti-Doping Agency prohibited by LC coupled with tandem mass spectrometer (MS/MS). For quantitation of ECD, the method was fully validated with outstanding performance characteristics (LOD: 35 µg·g−1, LOQ: 115 µg·g−1, CV% < 5%), resulting in significantly lower LOD and shorter runtime than published previously. For limit tests, a chromatographic method was developed to obtain excellent separation, while MS/MS parameters were optimised to allow the lowest possible reporting limit (RL: 0.6–10 ng·g−1 or mL−1). Twenty-one ecdysterone-containing DSs from ten brands were analysed. In all cases, the measured ECD content was much lower than labelled, and 20% of the samples contained a prohibited substance. The concentration of ecdysterone and contaminations varied randomly from batch to batch. The developed methods help to prevent the use of contaminated or useless DSs.
Overview
CoChat Summary
TL;DR
The paper validates LC-DAD quantitation of ecdysterone (ECD) and an LC-MS/MS limit test for 47 WADA-prohibited S1/S4 substances in ECD-containing dietary supplements. Across 21 products from 10 brands, measured ECD was generally far below label claims and some samples contained prohibited anabolic steroids.
Key findings
- The LC-DAD ECD method showed LOD 35 µg·g⁻¹, LOQ 115 µg·g⁻¹, linear range 1–50 µg·mL⁻¹, correlation coefficient 0.9999, and CV% < 5%; recoveries were within the 70–130% acceptance range, though one was close to the lowest limit.
- The LC-MS/MS limit test for 47 WADA-prohibited steroids, hormones, and metabolic modulators achieved reporting limits of 0.6–10 ng·g⁻¹ or mL⁻¹, with selectivity factor α > 1.5 for critical pairs.
- In 21 ECD-containing supplements from 10 brands, measured ECD was usually much lower than labelled; brand “A” had a CV% > 80% between batches, brand “I” had one batch with no detectable ECD and another at barely more than half its label, and the highest measured ECD was 34.1 mg/capsule in brand “F.”
- The abstract reports that 20% of samples contained a prohibited substance, while the Results section states 25% of samples contained a WADA S1-class prohibited substance; detected contaminants included 4(5)-androstene-3,17-dione and 1,4-androstene-3,17-dione.
Methods
- Samples were ECD-containing dietary supplements purchased online or received from the National Food Chain Safety Office (NFCSO), Hungary; 21 products from 10 brands were analysed, and method validation used solid samples (three capsules, one tablet) plus 11 diverse supplement matrices for the limit test.
- ECD was extracted with methanol, separated on a Kinetex C18 RP column, and quantified by LC-DAD at 254 nm using external calibration over 1–50 µg·mL⁻¹.
- Prohibited substances were analysed by LC-MS/MS on a triple quadrupole instrument using dynamic MRM; 49 steroids including ECD and an internal standard were separated, with positive ESI for most targets and negative ESI for LGD4033 and ostarine.
Limitations
- The paper states that one recovery was close to the lowest acceptance limit, presumably due to high herbal content, and recommends performing a recovery study for unknown or complex matrices.
- The paper notes no correlation between product source (webshop vs. authority) and actual composition, including active compound concentration and contamination.
- Evident from the text: the abstract and Results section disagree on the proportion of samples containing prohibited substances (20% vs. 25%), and the sample set is limited to 21 products from 10 brands, so broader supplement-market representativeness is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
6 Valid · 2 Not valid · 6 Not checked · 41 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In all cases, the measured ECDcontent was much lower than labelled”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The calculated recoveries (shown in Table 2) are satisfactory for each sample”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In most cases, the measured ECD content was noticeably lower than as they were labeled.”
- Also stated in: § 4. Conclusions 4. Conclusions · plain
“Serious discrepancies were explored on the labelling of supplements containing ECD, including the lack of active compounds and the presence of prohibited substances.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Conclusions 4. Conclusions · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CV% < 5%”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to the obtained values, the developed LC-DAD method has excellent repeatability. The CV% in every case was lower than 5% (Table 2).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
30 more claims
Create a free account to see all 55 claims and every source verdict.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 11
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Analysis of dietary supplements showed that ecdysterone levels ranged from 5 to 383 mg/g.[Citation54]”
From Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements (2024) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Grucza et al. confirmed significant discrepancies in the declared ecdysterone content and the real content through analytical tests.”
From Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements (2024) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, if 20E and contaminations are not specifically analyzed, any observed effects could potentially be related to contamination rather than the compound itself.”
From How reliable is the labeling of a commercial phytosteroid product? A 12-week randomized double-blind training study (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the inclusion of 20HE in World Anti-Doping Agency (WADA) monitoring programs since 2020 demonstrates the increased regulatory attention given to these substances [15,32,33].”
From Ecdysterone and Turkesterone—Compounds with Prominent Potential in Sport and Healthy Nutrition (2024) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“recent studies have shown that nearly 20% of tested 20E supplements contained impurities, including prohibited anabolic substances [34].”
From How reliable is the labeling of a commercial phytosteroid product? A 12-week randomized double-blind training study (2025) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Quantitation of Ecdysterone and Targeted Analysis of WADA-Prohibited Anabolic Androgen Steroids, Hormones, and Metabolic Modulators in Ecdysterone-Containing Dietary Supplements
“20% of the samples contained a prohibited substance”
§ 3.5. Analysis of ECD-Containing DSs
“25% of the samples contained a prohibited substance from the WADA S1 class”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Quantitation of Ecdysterone and Targeted Analysis of WADA-Prohibited Anabolic Androgen Steroids, Hormones, and Metabolic Modulators in Ecdysterone-Containing Dietary Supplements
“In all cases, the measured ECDcontent was much lower than labelled”
§ 3.5. Analysis of ECD-Containing DSs
“| E1 | capsule | Dietary supplement with with Maca extract, L -arginine, | webshop | n.d. | 3.41 | 3.4 | 2.5 | 2-3 |”
Citations
Cites
Athletes and Supplements: Prevalence and Perspectives
Garthe, I., & Maughan, R. J. (2018) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2017-0429 · Cited by 383
Nutritional supplements cross-contaminated and faked with doping substances
Geyer, H., Parr, M. K., Koehler, K., Mareck, U., Schänzer, W., & Thevis, M. (2008) · Journal of Mass Spectrometry · doi:10.1002/jms.1452 · Cited by 375
Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals
Dinan, L., & Lafont, R. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06900 · Cited by 200
Dietary Supplement and Food Contaminations and Their Implications for Doping Controls
Walpurgis, K., Thomas, A., Geyer, H., Mareck, U., & Thevis, M. (2020) · Foods · doi:10.3390/foods9081012 · Cited by 136
Isenmann, E., Ambrosio, G., Joseph, J. F., Mazzarino, M., de la Torre, X., Zimmer, P., Kazlauskas, R., Goebel, C., Botrè, F., Diel, P., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02490-x · Cited by 127
Dietary supplements as source of unintentional doping
Kozhuharov, V. R., Ivanov, K., & Ivanova, S. (2022) · BioMed Research International · doi:10.1155/2022/8387271 · Cited by 108
Detection and determination of anabolic steroids in nutritional supplements
De Cock, K. J. S., Delbeke, F. T., Van Eenoo, P., Desmet, N., Roels, K., & De Backer, P. (2001) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(01)00396-x · Cited by 96
Ecdysteroids: A novel class of anabolic agents?
Parr, M., Botrè, F., Naß, A., Hengevoss, J., Diel, P., & Wolber, G. (2014) · Biology of Sport · doi:10.5604/20831862.1144420 · Cited by 95
Poucke, C. V., Detavernier, C., Cauwenberghe, R. V., & Peteghem, C. V. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2006.09.050 · Cited by 80
Wilborn, C. D., Taylor, L. W., Campbell, B. I., Kerksick, C., Rasmussen, C. J., Greenwood, M., & Kreider, R. B. (2006) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-3-2-19 · Cited by 73
Neves, D. B. D. J., & Caldas, E. D. (2017) · Forensic Science International · doi:10.1016/j.forsciint.2017.03.016 · Cited by 71
Hunyadi, A., Herke, I., Lengyel, K., Báthori, M., Kele, Z., Simon, A., Tóth, G., & Szendrei, K. (2016) · Scientific Reports · doi:10.1038/srep37322 · Cited by 59
Todorova, V., Ivanov, K., & Ivanova, S. (2021) · Plants · doi:10.3390/plants11010064 · Cited by 56
Dietary supplements as a major cause of anti-doping rule violations
Lauritzen, F. (2022) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.868228 · Cited by 55
Leaney, A. E., Beck, P., Biddle, S., Brown, P., Grace, P. B., Hudson, S. C., & Mawson, D. H. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2908 · Cited by 47
Targeting the administration of ecdysterone in doping control samples
Parr, M. K., Ambrosio, G., Wuest, B., Mazzarino, M., de la Torre, X., Sibilia, F., Joseph, J. F., Diel, P., & Botrè, F. (2020) · Forensic Toxicology · doi:10.1007/s11419-019-00504-y · Cited by 38
Tircova, B., Bosáková, Z., & Kozlík, P. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2541 · Cited by 35
Ambrosio, G., Wirth, D., Joseph, J. F., Mazzarino, M., de la Torre, X., Botrè, F., & Parr, M. K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112877 · Cited by 25
A simple toxicological analysis of anabolic steroid preparations from the black market
Pellegrini, M., Rotolo, M. C., Di Giovannadrea, R., Pacifici, R., & Pichini, S. (2012) · Annales de Toxicologie Analytique · doi:10.1051/ata/2012011 · Cited by 23
Kozlík, P., & Benická, B. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.008 · Cited by 22
Micalizzi, G., Huszti, K., Pálinkás, Z., Mandolfino, F., Martos, É., Dugo, P., Mondello, L., & Utczás, M. (2021) · Drug Testing and Analysis · doi:10.1002/dta.2929 · Cited by 16
Self-citationDinan, L., Balducci, C., Guibout, L., & Lafont, R. (2020) · Phytochemical Analysis · doi:10.1002/pca.2930 · Cited by 14
Napierała, M., Nawrot, J., Gornowicz-Porowska, J., Florek, E., Moroch, A., Adamski, Z., Kroma, A., Miechowicz, I., & Nowak, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186453 · Cited by 14
Grucza, K., Wicka, M., Drapała, A., & Kwiatkowska, D. (2021) · Separations · doi:10.3390/separations9010008 · Cited by 14
Ecdysterone: Possible sources of origin in urine
Kwiatkowska, D., Grucza, K., Chajewska, K., Konarski, P., Wojtkowiak, K., Drapała, A., & Wicka, M. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3420 · Cited by 10
Targeting the Administration of Ecdysterone in Doping Control SamplesPreprint
Parr, M. K., Ambrosio, G., Wuest, B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/685230 · Cited by 6
Research works printed but not linked: 1
- Schänzer, W., Geyer, H., Gotzman, A., and Mareck, U. (2012). Recent Advances in Dope Analysis, Proceedings of the Manfred-Donike-Workshop; 30th Cologne Workshop on Dope Analysis, 26th February to 2nd March 2012, Sport und Buch Strauß.
Cited by
Wenbo, Z., & Zhang, Y. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s439384 · Cited by 74
“93 Lipid profiling in individuals with AAS abuse revealed an increased amount of free fatty acids and glycerophospholipids.”
BackgroundEcdysterone and Turkesterone—Compounds with Prominent Potential in Sport and Healthy Nutrition
Todorova, V., Ivanova, S., Chakarov, D., Kraev, K., & Ivanov, K. (2024) · Nutrients · doi:10.3390/nu16091382 · Cited by 31
Todorova, V., Ivanov, K., Karcheva-Bahchevanska, D., & Ivanova, S. (2023) · Processes · doi:10.3390/pr11061786 · Cited by 13
Todorova, V., Ivanova, S., Yotov, V., Zaytseva, E., Ardasheva, R., Turiyski, V., Prissadova, N., & Ivanov, K. (2024) · Molecules · doi:10.3390/molecules29215145 · Cited by 7
Todorova, V., Todorova, M. N., Savova, M. S., Ivanov, K., Georgiev, M. I., & Ivanova, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083739 · Cited by 8
“…studies Sida tuberculata R. E. Fries, Zuo Gui Wan, and other plant extracts [37–39], as well quantification of ecdysterone in dietary supplements [40,41] and It offers high sensitivity, reproducibility, and detailed chromatographic profiles, making HPLC essential for quality control [36]. in human…”
Metadata
- Authors
- Pálinkás, Z., Békési, D., & Utczás, M.
- Affiliations
- Hungarian University of Sports Science (HU)
- Semmelweis University (HU)
- Corresponding author
- Utczás, Margita
- Venue
- Separations
- Publisher
- MDPI AG
- Published
- 2023-04-05
- Volume
- 10
- Issue
- 4
- Pages
- 242
- ISSN
- 2297-8739 (ISSN-L)
- OpenAlex
- W4362608545
- Semantic Scholar
- f426e0725afd60ee6fe47faa9abe43399343855a
- Cited by
- 11
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Separations (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- 20-hydroxyecdysone, dietary supplements, anti-doping, limit test, method validation, LC-MS/MS, LC-DAD, supplement contamination, metabolic modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

